Officials effectively said a medicine can qualify for a special pricing arrangement if it met the criteria at a given point in time or some but not all of the criteria subsequently. …
New Stories
-
Pfizer's 'celebrity doctor' on humanising the industry
August 16, 2018 - - PharmaDispatch Executive -
Patient access at risk over PBAC fee waiver
August 16, 2018 - - Latest News -
Investors cheer CSL result and outlook
August 16, 2018 - - Latest News -
FDA approval for Pharmaxis manufacturing facility
August 16, 2018 - - Latest News -
Transparency is the first step
August 15, 2018 - - Comment -
TGA approval for Allergan eye implant
August 15, 2018 - - Latest News -
Vertex: Working towards reimbursement
August 14, 2018 -